Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Total Debt (2020 - 2025)

Agilon Health (AGL) has disclosed Total Debt for 6 consecutive years, with $35.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Debt changed 0.38% year-over-year to $35.0 million, compared with a TTM value of $35.0 million through Dec 2025, changed 0.38%, and an annual FY2025 reading of $35.0 million, changed 0.38% over the prior year.
  • Total Debt was $35.0 million for Q4 2025 at Agilon Health, roughly flat from $35.0 million in the prior quarter.
  • Across five years, Total Debt topped out at $99.4 million in Q1 2021 and bottomed at $34.9 million in Q3 2024.
  • Average Total Debt over 5 years is $43.7 million, with a median of $40.4 million recorded in 2023.
  • The sharpest move saw Total Debt tumbled 52.55% in 2022, then grew 0.38% in 2025.
  • Year by year, Total Debt stood at $48.4 million in 2021, then dropped by 10.16% to $43.5 million in 2022, then decreased by 11.32% to $38.6 million in 2023, then fell by 9.48% to $34.9 million in 2024, then grew by 0.38% to $35.0 million in 2025.
  • Business Quant data shows Total Debt for AGL at $35.0 million in Q4 2025, $35.0 million in Q3 2025, and $34.9 million in Q2 2025.